Chemomab Therapeutics (CMMB) Other Working Capital Changes (2018 - 2023)
Chemomab Therapeutics (CMMB) posted Other Working Capital Changes of $20000.0 for Q4 2023, up 2100.0% on a QoQ basis from -$1000.0 in Q3 2023, and up 400.0% year-over-year from $4000.0 in Q4 2022.
Chemomab Therapeutics (CMMB) Other Working Capital Changes (2018 - 2023) Analysis & Trends
Chemomab Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $20000.0 for Q4 2023.
- Quarterly Other Working Capital Changes rose 400.0% year-over-year to $20000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $13000.0 (up 218.18% YoY) and the FY2025 annual result came in at -$35000.0, down 200.0% from the prior year.
- Other Working Capital Changes was $20000.0 for Q4 2023 at Chemomab Therapeutics, up from -$1000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.6 million in Q2 2021 and bottomed at -$3.0 million in Q3 2019.
- A 5-year average of -$49350.0 and a median of -$10000.0 in 2020 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 400.0% in 2023, while the deepest fall reached 125.0% in 2023.
- Chemomab Therapeutics' Other Working Capital Changes stood at -$123000.0 in 2019, then soared by 98.37% to -$2000.0 in 2021, then soared by 300.0% to $4000.0 in 2022, then surged by 400.0% to $20000.0 in 2023.
- Business Quant data shows CMMB's Other Working Capital Changes at $20000.0 in Q4 2023, -$1000.0 in Q3 2023, and -$3000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Chemomab Therapeutics | 704.11 Mn | 693.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1.88 Mn |
| Dec 31, 2023 | -1.88 Mn |
| Dec 31, 2023 | -1.88 Mn |
| Sep 30, 2023 | 163,000.00 |
| Sep 30, 2023 | 163,000.00 |
| Sep 30, 2023 | 163,000.00 |
| Jun 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | -814,000.00 |
| Mar 31, 2023 | -814,000.00 |
| Mar 31, 2023 | -814,000.00 |
| Dec 31, 2022 | 664,000.00 |
| Dec 31, 2022 | 664,000.00 |
| Dec 31, 2022 | 664,000.00 |
| Sep 30, 2022 | 883,000.00 |
| Sep 30, 2022 | 883,000.00 |
| Sep 30, 2022 | 883,000.00 |
| Jun 30, 2022 | -1.85 Mn |
| Jun 30, 2022 | -1.85 Mn |